Table 1.
Clinical and epidemiological characteristics of admitted patients (n = 103)
| Characteristic | n (%) |
|---|---|
| Age, median (IQR) (years) | 60 (51–69) |
| Place of residence | |
| Home | 103 (100) |
| Supported living | 0 (0) |
| Residential care facility | 0 (0) |
| Acquisition of COVID‐19 | |
| Cruise ship | 36 (35) |
| Overseas travel | 50 (49) |
| Interstate travel | 1 (1) |
| Confirmed community contact | 13 (13) |
| Unknown contact | 3 (3) |
| Sex | |
| Male | 55 (53) |
| Female | 48 (47) |
| Comorbidities | |
| Cardiovascular | 16 (16) |
| Respiratory | 19 (18) |
| Hypertension | 37 (36) |
| ACE inhibitor/ARB use | 33 (32) |
| Diabetes | 18† (17) |
| CKD (stage 3B) | 2 (1.9) |
| Immunosuppressed | 6 (5.8) |
| BMI >30 (where known, n = 71) (kg/m²) | 24 (14) |
| DNR order | 7 (6.7) |
†
2 = insulin dependent.
ACE, angiotensin‐converting enzyme; ARB, angiotensin receptor blocker; BMI, body mass index; CKD, chronic kidney disease; DNR, do not resuscitate.